Solve M.E. and BIO co-host “Long Covid: What Will It Take To Accelerate Therapeutic Progress?”
Solve M.E. and The Biotechnology Innovation Organization (BIO) will co-host a three-hour virtual event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?” on Tuesday, February 21 from 10:00 […]
Long Covid After One Year: The Good News & the Bad News
“Mild Covid-19 disease does not lead to serious or chronic long term morbidity in the vast majority of patients” was the headline in most media coverage of an important study […]
Thank you! Your support fuels big plans!
What a way to close out 2022! We are so grateful for your generosity throughout the year, and especially during our recent year-end campaign. Thank you for helping us surpass […]
An Evolving Landscape: Long Covid’s Impact on ME/CFS
It’s hard to believe that we’re well into the third year of the COVID-19 pandemic, which coincidentally overlaps with my time as Solve M.E.’s President and CEO. In this time […]
Solve Awarded Nearly $250k from Chan Zuckerberg Initiative to Fund Bold New Program
We’re thrilled to announce that the Chan Zuckerberg Initiative (CZI) has awarded Solve M.E. a significant grant in support of our Long Covid Patient Leader Advancement Network (LC-PLAN), a groundbreaking […]
Solve M.E. Leaders Join Milken Future of Health Summit
This week, the Milken Institute hosted their annual Future of Health Summit. Solve CEO & President Oved Amitay and Solve Board Member Cynthia Adinig joined other leaders in a panel […]
RECOVER Study of Paxlovid to Treat Long Covid Begins January 2023, Has Implications for ME/CFS
The National Institutes of Health (NIH) announced that the use of Paxlovid to treat Long Covid will be the first treatment to be studied by its $1 billion RECOVER Initiative. […]
Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid
A decade after the U.S. Food and Drug Administration (FDA) did not approve Ampligen (rintatolimod) for the treatment of ME/CFS, this antiviral and immuno-modulator drug is getting a rare second chance. […]
Study Reveals First Genetic Links in ME/CFS, Could Accelerate Development of New Treatments
Oxford-based biotech company PrecisionLife announced that their combinatorial analysis of genetic data links 14 genes to ME/CFS and identifies many patient subgroups. According to a press release, “This is the […]
World ME Alliance Members “Do Not Endorse the Lightning Process”
This article was first published by our friends at the World ME Alliance. Read it here. The World ME Alliance and its members have worked closely over the past few […]
Solve M.E. Welcomes Chief Operating Officer TaKeisha S. Walker
Solve M.E. is pleased to announce that TaKeisha S. Walker recently joined us as chief operating officer. In this newly-created role reporting to CEO Oved Amitay, TaKeisha will lead Solve’s […]
Signature Event Summary — Long Covid: Research, Policy and Economic Impact
As part of our efforts via the Solve Long Covid Initiative, we’ve partnered with the Global Interdependence Center on a year-long webinar and conference series exploring the pandemic’s long-term healthcare, […]
